Preclinical and Clinical evaluation of the effect on oral administration of "MANTHARA KAASA LEGIYAM" in the management of "PRIMARY COMPLEX" in children

Preclinical and Clinical evaluation of the effect on oral administration of "MANTHARA KAASA LEGIYAM" in the management of "MANTHARA KANAM(PRIMARY COMPLEX)" in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/046963

Enrollment

Registered

2022-11-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: MANTHARA KAASA LEGIYAM: Should be administered orally twice a day after meal with milk for 48 days Dosage 3 to 4 years-2 grams 5 to 7 years-3 grams Control Intervention1: Nil: N

Eligibility

Inclusion criteria

Inclusion criteria: Cough Difficulty in breathing Evening rise of temperature Gradual reduction in weight Indigestion Fatigue Night sweats Lethargy

Exclusion criteria

Exclusion criteria: Protein Energy Malnutrition(PEM) Congenital Cardiac Disease Sputum positive tuberculosis Pneumonia Respiratory Distress Syndrome(RDS) Whopping cough Pyrexia of Unknown Origin(PUO) Gastro Esophageal Reflux Disease(GERD)

Design outcomes

Primary

Measure	Time frame
This study will help to understand the effects of MANTHARA KAASA LEGIYAM in the management of MANTHARA KANAM(PRIMARY COMPLEX) in children and the specific symptoms will expected to be curedTimepoint: 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr SHYAMALA MDs

Government Siddha Medical College and Hospital Palayamkottai Tirunelveli

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026